Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women’s Health Initiative Randomized Clinical Trials | Zendy

Rowan T. Chlebowski | Zendy; Garnet L. Anderson | Zendy; Aaron K. Aragaki | Zendy; JoAnn E. Manson | Zendy; Marcia L. Stefanick | Zendy; Kathy Pan | Zendy; Wendy E. Barrington | Zendy; Lewis H. Kuller | Zendy; Michael S. Simon | Zendy; Dorothy S. Lane | Zendy; Karen Johnson | Zendy; Thomas E. Rohan | Zendy; Margery Gass | Zendy; Jane A. Cauley | Zendy; Electra D. Paskett | Zendy; Maryam Sattari | Zendy; Ross L. Prentice | Zendy

Open Access

Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women’s Health Initiative Randomized Clinical Trials

Author(s) -

Rowan T. Chlebowski,

Garnet L. Anderson,

Aaron K. Aragaki,

JoAnn E. Manson,

Marcia L. Stefanick,

Kathy Pan,

Wendy E. Barrington,

Lewis H. Kuller,

Michael S. Simon,

Dorothy S. Lane,

Karen Johnson,

Thomas E. Rohan,

Margery Gass,

Jane A. Cauley,

Electra D. Paskett,

Maryam Sattari,

Ross L. Prentice

Publication year - 2020

Publication title -

jama

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.688

H-Index - 680

eISSN - 1538-3598

pISSN - 0098-7484

DOI - 10.1001/jama.2020.9482

Subject(s) - medicine , breast cancer , randomized controlled trial , medroxyprogesterone acetate , women's health initiative , hormone therapy , hormone replacement therapy (female to male) , placebo , clinical trial , gynecology , incidence (geometry) , cancer , observational study , estrogen , physics , alternative medicine , pathology , optics , testosterone (patch)

The influence of menopausal hormone therapy on breast cancer remains unsettled with discordant findings from observational studies and randomized clinical trials.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research